Expert Warns 'Miracle' Weight Loss Drug Ozempic Might Require Lifelong Use: 'Are You Prepared...?'

Health experts have warned that the popular weight loss drug, Ozempic, may need to be taken for life to maintain weight loss, Daily Mail reports.

Understanding the Concern: According to Professor Carel Le Roux, an expert in metabolic medicine at Ulster University, “These are treatments for the disease of obesity. The minute you stop the drug, the disease relapses.”

This comes amid pleas for slim individuals not to jump onto a celeb-inspired craze to use the weight loss jabs.

See Also: Stop Making People Feel Bad: Plastic Surgeon Lambasts Ozempic Shaming

The Impact on Diabetic Patients: Unnecessary demand for the drug also threatens to interrupt supply for Type 2 diabetics. Ozempic is the only semaglutide available in the U.K. currently.

Long-term Treatment: Experts argue that the guidance for the drug’s usage is largely based on the cost of the drugs and that users should be prepared to take them longer-term.

“The minute we stop the drug, the disease (obesity) relapses, so one of the most important questions we ask our patients now is, ‘are you prepared to take this treatment for the rest of your life?’,” said Professor Le Roux.

The ‘miracle’ weight loss drug is being endorsed by celebrities like Amy Schumer, Kim Kardashian, and Tesla CEO Elon Musk.

Read Next: Ozempic Alternatives: These Two Drugs Show Promise in Affordability and Effectiveness for Weight Loss

Image By Natalia Varlei On Shutterstock.


Engineered by Benzinga Neuro, Edited by Pooja Rajkumari


The GPT-4 Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.


Market News and Data brought to you by Benzinga APIs
Posted In: NewsHealth CareMediaGeneralDiabetesOzempicwegovyweightloss
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...